Biography
Dr Daniela Pereira Carvalho is a Research Associate within the Peter Gorer Department of Immunobiology and the Department of Women and Children's Health at the Guy's and St Thomas' hospitals. Daniela completed her PhD at the Federal University of Rio de Janeiro in 2022, including one year as a visiting PhD student at the University of Cambridge in 2021.
Before commencing at the King’s College London in 2023, Daniela's research focussed on translational research related to pregnancy associated conditions, such as maternal infection, and changes in fetal and placental growth. Now at the King’s College London, Daniela is working on the Prenatal Drivers of Infant Islet Cell Autoimmunity (PISA) study. Her aim is to investigate the impact of different maternal exposures on the development of islet autoimmunity in infants, identifying relationships between the in utero inflammatory environment and the risk of T1D development.
Research
Gibbons Group
Every year, 15 million babies are born prematurely and 1 million die as a consequence. My lab focuses on understanding immune cell development and function in human neonates, including both those born at term and prematurely. We have identified novel T cell effector functions in neonates and factors that affect immune cell development post birth. We have ongoing research in both areas. These studies will promote our understanding of the developing immune system in human infants to identify those more at risk from inflammation and infection and subsequently reduce infant mortality - a current NHS target and huge health burden.
INSIGHT-2
Mechanistic Studies into Pregnancy Complications and their Impact on Maternal and Child Health
Tribe Lab
Through our mother-child cohorts, our goal is to improve outcomes for pregnant women and their children and promote health throughout the life course.
PISA: Prenatal drivers of infant ISlet Autoimmunity
The PISA study will test the idea that different exposures in pregnancy may influence fetal development to increase the risk of childhood autoimmunity.
Project status: Ongoing
Research
Gibbons Group
Every year, 15 million babies are born prematurely and 1 million die as a consequence. My lab focuses on understanding immune cell development and function in human neonates, including both those born at term and prematurely. We have identified novel T cell effector functions in neonates and factors that affect immune cell development post birth. We have ongoing research in both areas. These studies will promote our understanding of the developing immune system in human infants to identify those more at risk from inflammation and infection and subsequently reduce infant mortality - a current NHS target and huge health burden.
INSIGHT-2
Mechanistic Studies into Pregnancy Complications and their Impact on Maternal and Child Health
Tribe Lab
Through our mother-child cohorts, our goal is to improve outcomes for pregnant women and their children and promote health throughout the life course.
PISA: Prenatal drivers of infant ISlet Autoimmunity
The PISA study will test the idea that different exposures in pregnancy may influence fetal development to increase the risk of childhood autoimmunity.
Project status: Ongoing